Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Initial determination setting target Date - ITC (MMP)

337-TA-853

Order No. 3: Initial Determination setting Target Date

Upon review of the Complaint and the Notice of Investigation, and taking into account the ALJ’s commitments in other Investigations already instituted, the ALJ has determined that a target date exceeding sixteen months is appropriate. There is no room in the ALJ’s schedule for a ten-day hearing until June of 2013. Adequate time must further be allocated for post-hearing briefing and analysis. Accordingly, a target of January 6, 2013 is set for this Investigation. Based on this target date, the final initial determination on violation in this Investigation

Share
New Message
Please login to post a reply